Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,568 | -20,656 | -14,288 | -15,712 | -26,431 |
| Depreciation Amortization | N/A | 27 | 45 | 41 | 52 |
| Other Working Capital | 1,455 | 2,017 | -1,716 | 512 | 37 |
| Other Operating Activity | 516 | 11,320 | 731 | 1,688 | 9,389 |
| Operating Cash Flow | $-8,597 | $-7,291 | $-15,229 | $-13,470 | $-16,953 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 64 | -116 | -44 | N/A |
| Purchase Sale Intangibles | N/A | -1,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -1,000 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $-936 | $-116 | $-44 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -564 | N/A | 132 |
| Common Stock Issued | 6,672 | 850 | 69 | 29,301 | 16,522 |
| Other Financing Activity | -693 | -566 | 0 | -6,161 | -329 |
| Financing Cash Flow | $5,979 | $284 | $-495 | $23,140 | $16,325 |
| Beginning Cash Position | 3,484 | 11,427 | 27,266 | 17,640 | 18,268 |
| End Cash Position | 865 | 3,484 | 11,427 | 27,266 | 17,640 |
| Net Cash Flow | $-2,619 | $-7,943 | $-15,839 | $9,626 | $-628 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,597 | -7,291 | -15,229 | -13,470 | -16,953 |
| Capital Expenditure | N/A | N/A | -128 | -44 | N/A |
| Free Cash Flow | -8,597 | -7,291 | -15,356 | -13,514 | -16,953 |